Daniela Boggiani
Impact in
-
- Lung Cancer Research Studies
- HER2/EGFR in Cancer Research
-
- Cancer Genomics and Diagnostics
- Breast Cancer Treatment Studies
Papers in
-
- Breast Cancer Treatment Studies 5
- Cancer Genomics and Diagnostics 2
- Oncology 9
- HER2/EGFR in Cancer Research 5
- PARP inhibition in cancer therapy 2
- Co-authors
- Andrea ArdizzoniAntonino MusolinoBeatrice BortesiCecilia BozzettiMarcello TiseoGabriella SammarelliMarco BartolottiFrancesco Gelsomino
- Journals
- Journal of Clinical Oncology (2 papers)Frontiers in Oncology (2 papers)Cancer (1 paper)Cancers (1 paper)Lung Cancer (1 paper)
- Partner nations
- ItalyFranceUnited States
In The Last Decade
Daniela Boggiani
15 papers receiving 277 citations
Peers
Comparison fields: 5 of 40
- Oncology 195
- Cancer Research 80
- Pulmonary and Respiratory Medicine 123
- Pathology and Forensic Medicine 59
- Neurology 26
Countries citing papers authored by Daniela Boggiani
This map shows the geographic impact of Daniela Boggiani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniela Boggiani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniela Boggiani more than expected).
Fields of papers citing papers by Daniela Boggiani
This network shows the impact of papers produced by Daniela Boggiani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniela Boggiani. The network helps show where Daniela Boggiani may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Daniela Boggiani, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 9 | |
| 2 | 2021 | 8 | |
| 3 | 2021 | 1 | |
| 4 | 2020 | 14 | |
| 5 | 2020 | 4 | |
| 6 | 2019 | 22 | |
| 7 | 2017 | 3 | |
| 8 | 2017 | 16 | |
| 9 | 2016 | 20 | |
| 10 | Triple negative status and BRCA mutations in contralateral breast cancer: a population-based study. | 2016 | 6 |
| 11 | 2015 | 13 | |
| 12 | 2015 | 1 | |
| 13 | 2012 | 22 | |
| 14 | 2010 | 36 | |
| 15 | 2010 | 104 |
About Daniela Boggiani
Daniela Boggiani is a scholar working on Cancer Research, Oncology, Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine and Dermatology, having authored 15 papers that have together received 279 indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (5 papers), HER2/EGFR in Cancer Research (5 papers), Advanced Breast Cancer Therapies (4 papers), BRCA gene mutations in cancer (3 papers), Cancer Genomics and Diagnostics (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers), PARP inhibition in cancer therapy (2 papers) and Breast Lesions and Carcinomas (2 papers). The work is most often cited by research in Oncology (195 citations), Cancer Research (80 citations), Pulmonary and Respiratory Medicine (123 citations), Pathology and Forensic Medicine (59 citations) and Neurology (26 citations). Daniela Boggiani has collaborated with scholars based in Italy, France and United States. Frequent co-authors include Andrea Ardizzoni, Antonino Musolino, Beatrice Bortesi, Cecilia Bozzetti, Marcello Tiseo, Gabriella Sammarelli, Marco Bartolotti, Francesco Gelsomino, Maria Michiara and Benedetta Pellegrino. Their work appears in journals such as Journal of Clinical Oncology, Frontiers in Oncology, Cancer, Cancers and Lung Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.